Vor Biopharma Inc

NASDAQ:VOR  
12.97
-1.12 (-7.95%)
Products, Strategic Combinations

Vor Biopharma Announces Collaboration With Janssen To Develop Treatment For Acute Myeloid Leukemia (Aml)

Published: 07/08/2021 12:22 GMT
Vor Biopharma Inc (VOR) - Vor Biopharma Announces Collaboration With Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-specific Antibody Therapy for Acute Myeloid Leukemia (aml).
Vor Biopharma Inc - Under Terms of Collaboration, Vor Biopharma Will Investigate Combination of These Two Technologies Into a Treatment Solution.
Vor Biopharma Inc - Collaboration Agreement Provides That Each Company Retains All Rights and Ownership to Their Respective Programs and Platforms.